IodoFinder: Machine Learning-Guided Recognition of Iodinated Chemicals in Nontargeted LC-MS/MS Analysis
- Environ Sci Technol. 2025 Mar 11;59(9):4530-4539. doi: 10.1021/acs.est.4c12698.
- 1. Department of Chemistry, Faculty of Science, University of British Columbia, Vancouver Campus, 2036 Main Mall, Vancouver, British Columbia V6T 1Z1, Canada.
- 2. Division of Analytical and Environmental Toxicology, Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta T6G 2G3, Canada.
Iodinated disinfection byproducts (I-DBPs) pose significant health concerns due to their high toxicity. Current approaches to recognize unknown I-DBPs in mass spectrometry (MS) analysis rely on negative ionization mode, in which the characteristic I- fragment can be observed in tandem mass spectra (MS/MS). Still, many I-DBPs ionize exclusively in positive ionization mode, where the I- fragment is absent. To address this gap, this work developed a machine learning-based strategy to recognize iodinated compounds (I-compounds) from their MS/MS in both electrospray positive (ESI+) and negative ionization (ESI-) modes. Investigating over 6000 MS/MS spectra of 381 I-compounds, we first identified five characteristic I-containing neutral losses and one diagnostic I- fragment in ESI+ and ESI- modes, respectively. We then trained Random Forest models and integrated them into IodoFinder, a Python program, to streamline the recognition of I-compounds from raw LC-MS data. IodoFinder accurately recognized over 96% of the 161 I-compound standards in both ionization modes. In its application to DBP mixtures, IodoFinder discovered 19 I-DBPs with annotated structures and an additional 17 with assigned formulas, including 12 novel and 3 confirmed I-DBPs. We envision that IodoFinder will advance the identification of both known and unknown I-compounds in exposome studies.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
-
target: STINGResearch Areas: Inflammation/Immunology
-
Research Areas: Metabolic Disease
-
-
Research Areas: Endocrinology
-
target: DNA/RNA SynthesisResearch Areas: Cancer
-
target: Thyroid Hormone ReceptorResearch Areas: Endocrinology
-
98.0%, Antibacterial Agent, Antiviral Agent, Mutagenic Agent, Antiparasitic Agent
-
Research Areas: Cardiovascular Disease
-
-
target: Biochemical Assay ReagentsResearch Areas: Others
-
target: Thyroid Hormone Receptor
-
target: Drug IntermediateResearch Areas: Others
-
target: DYRKResearch Areas: Neurological Disease
-
target: HSP
-
-
target: Endogenous MetaboliteResearch Areas: Others
-
target: Nucleoside Antimetabolite/AnalogResearch Areas: Others
-
target: PROTAC LinkersResearch Areas: Cancer
-
target: Biochemical Assay ReagentsResearch Areas: Inflammation/Immunology
-
target: Biochemical Assay ReagentsResearch Areas: Others
-
target: Ligands for E3 LigaseResearch Areas: Cancer
-
target: Drug IntermediateResearch Areas: Others
-
target: Biochemical Assay ReagentsResearch Areas: Others
-
Research Areas: Others
-
target: Biochemical Assay ReagentsResearch Areas: Others